Notes
NPRA = National Pharmaceutical Regulatory Agency
Reference
National Pharmaceutical Regulatory Agency, Ministry of Health Malaysia. Xylometazoline: Increased Risk of Serious Ventricular Arrhythmia in Patients with Long QT Syndrome. Internet Document : 15 Mar 2019. Available from: URL: https://www.npra.gov.my/index.php/en/component/content/article/414-english/safety-alerts-main/safety-alerts-2019/
Rights and permissions
About this article
Cite this article
Xylometazoline linked with risk of serious arrhythmias?. Reactions Weekly 1746, 5 (2019). https://doi.org/10.1007/s40278-019-59443-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-019-59443-7